rs111724149
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs35090414
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs1801195
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A significant interaction with BMI was only observed for WRN (rs1801195; P = 0.004) for T-cell lymphoma and ERCC2 (rs13181; P = 0.002) for diffuse large B-cell lymphoma.
|
23619945 |
2013 |
rs13181
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A significant interaction with BMI was only observed for WRN (rs1801195; P = 0.004) for T-cell lymphoma and ERCC2 (rs13181; P = 0.002) for diffuse large B-cell lymphoma.
|
23619945 |
2013 |
rs1227230819
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A single-base substitution was found in exon 1 (227G>A) of the XBP1 gene in a patient with diffuse large B-cell lymphoma, resulting in a somatic missense mutation (R76K).
|
19380033 |
2009 |
rs1312391542
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A single-base substitution was found in exon 1 (227G>A) of the XBP1 gene in a patient with diffuse large B-cell lymphoma, resulting in a somatic missense mutation (R76K).
|
19380033 |
2009 |
rs770027749
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A single-base substitution was found in exon 1 (227G>A) of the XBP1 gene in a patient with diffuse large B-cell lymphoma, resulting in a somatic missense mutation (R76K).
|
19380033 |
2009 |
rs2231142
|
|
|
0.010 |
GeneticVariation |
BEFREE |
ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy.
|
19032367 |
2008 |
rs1800797
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, rs1800797 was significantly association with breast cancer, non-Hodgkin's lymphoma, B-cell lymphoma and diffuse large B-cell lymphoma but not gastric cancer.
|
29552316 |
2018 |
rs12917
|
|
|
0.010 |
GeneticVariation |
BEFREE |
After stratification by major NHL histological subtypes, MGMT (rs12917) modified the association between chlorinated solvents and the risk of diffuse large B-cell lymphoma (Pfor interaction=0.0027) and follicular lymphoma (Pfor interaction=0.0024).
|
22430443 |
2012 |
rs121913250
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.
|
9139869 |
1997 |
rs121913530
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.
|
9139869 |
1997 |
rs121913237
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.
|
9139869 |
1997 |
rs121913529
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.
|
9139869 |
1997 |
rs1057519695
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.
|
9139869 |
1997 |
rs1057519834
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.
|
9139869 |
1997 |
rs11554290
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.
|
9139869 |
1997 |
rs121913240
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene.
|
9139869 |
1997 |
rs2736098
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Association of MNS16A VNTR and hTERT rs2736098: G>A polymorphisms with susceptibility to diffuse large B-cell lymphoma.
|
28967095 |
2018 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
|
27048211 |
2016 |
rs1390458638
|
|
|
0.010 |
GeneticVariation |
BEFREE |
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
|
27048211 |
2016 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
|
27923841 |
2017 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.
|
28496180 |
2017 |
rs20551
|
|
|
0.010 |
GeneticVariation |
BEFREE |
EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP.
|
28725161 |
2017 |
rs7712513
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
|
26460308 |
2015 |